@conference{f23db1c8fec043eea7b7aed8a2cc1b37,
title = "Randomized Phase II Trial of Re-Irradiation and Concurrent Bevacizumab versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma (NRG Oncology/RTOG 1205): Initial Outcomes and RT Plan Quality Report",
author = "C. Tsien and S. Pugh and A.P. Dicker and J.J. Raizer and M.M. Matuszak and E. Lallana and J. Huang and O. Algan and N. Taylor and L. Portelance and J. Villano and J. Hamm and K.S. Oh and A.N. Ali and M.M. Kim and S. Lindhorst and M.P. Mehta",
year = "2019",
month = sep,
day = "1",
doi = "10.1016/j.ijrobp.2019.06.539",
language = "American English",
note = "International Journal of Radiation Oncology Biology Physics ; Conference date: 01-09-2019",
}